Have you been diagnosed with a B cell disease that has returned after your previous treatment or is not responding to your current treatment? If so, you might be able to take part in a study to see if a new treatment is safe and can help treat people with B-cell diseases.

The purpose of this research study is to learn more about the risk of severe and fatal infusion-related reactions (IRR) in patients with multiple myeloma who are treated with their first 3 administrations of daratumumab. Examples of severe IRR include lung tightness, low oxygen levels, difficulty breathing, high blood pressure, racing heart, headache, and too much fluid in the lungs. No fatal IRRs have been observed in clinical trials of daratumumab. We are also doing this study to help us to identify potential risk factors for IRR.

The purpose of this study is to identify why households waste food. Using these causes of household food waste, we will work with participants to develop a comprehensive packet of tools that can be implemented in their daily lives to prevent food waste.

Have you ever wondered what environmental toxins you are exposed to on a daily basis, and how it might affect your health? The STRIVE study is looking for volunteers who would like to provide blood, urine, and/or saliva, as well as home samples such as soil, dust, and/or water. In this study, we want to learn more about the environmental factors that contribute to advanced liver disease and liver cancer. We are looking for healthy volunteers and people with liver cirrhosis who live in either North Carolina or Georgia to take part.

Do you have cervical cancer and are confused about health insurance or paying for your healthcare? We want to hear your thoughts on what might make it easier to navigate the financial side of cancer treatment. Your participation will help us to build a program to help cervical cancer patients like you. Compensation provided.

Do you have Non-Small Cell Lung Cancer? Have you previously been treated with Osimertinib? If so, you may be eligible for a trial comparing osimertinib in combination with other medications to treat your lung cancer. Please reach out if you're interested!

This research study aims to use electroencephalography (EEG) to refine our understanding of the neural mechanisms involved in suppressing distracting information.

In this project, we want to learn more about transgender and nonbinary individuals' sexual satisfaction. Sexual satisfaction is a prominent indicator of an individual's well-being and satisfaction with life. Current research focuses mainly on cisgender heterosexual populations. By focusing on people who identify under the nonbinary umbrella, in addition to binary-identifying trans people, we hope to examine how gender, the sociopolitical world, and a person's sexual satisfaction all intersect.

Finding new drugs is a long, expensive process. Drug repurposing, using an old drug for a new disorder, can make this process shorter and cheaper, and can occur by chance when a patient has two medical conditions that are treatable by the same drug. We hope that including you, the consumer, as a partner in drug development through self-report of unexpected benefits from medicinal agents could identify some with potential for repurposing. Your responses to a short Social Media survey may help you and others in the future.

Do you have a child between 12-14 years of age who is healthy but has some symptoms of anxiety or unexplained nervousness? You may be able to take part in a study with your child to better understand how anxiety develops across adolescence in brain and stress responses. Compensation provided.